Drug Shortages : Effect on Parenteral Nutrition Therapy
© 2018 American Society for Parenteral and Enteral Nutrition..
Drug shortages continue to be a threat to the health and welfare of numerous patients in the United States. For patients who depend on parenteral nutrition (PN) for survival, these shortages pose an even greater threat. Almost 75% of active drug shortages are sterile injectables, which includes PN components. Providing PN therapy is particularly challenging for clinicians because this is a complex medication and may contain 40 or more individual ingredients, of which multiple components may simultaneously be in limited supply. The availability of PN components must be considered during every step of the PN use process from ordering the PN prescription to administering this therapy to a patient. Alterations to a standardized process can lead to medication errors that can adversely affect patient outcomes and consume healthcare resources.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
---|---|
Enthalten in: |
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition - 33(2018), 1 vom: 24. Feb., Seite 53-61 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Holcombe, Beverly [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adverse events |
---|
Anmerkungen: |
Date Completed 05.09.2018 Date Revised 05.09.2018 published: Print Citation Status MEDLINE |
---|
doi: |
10.1002/ncp.10052 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM280268025 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM280268025 | ||
003 | DE-627 | ||
005 | 20231225024940.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/ncp.10052 |2 doi | |
028 | 5 | 2 | |a pubmed24n0934.xml |
035 | |a (DE-627)NLM280268025 | ||
035 | |a (NLM)29365360 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Holcombe, Beverly |e verfasserin |4 aut | |
245 | 1 | 0 | |a Drug Shortages |b Effect on Parenteral Nutrition Therapy |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.09.2018 | ||
500 | |a Date Revised 05.09.2018 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2018 American Society for Parenteral and Enteral Nutrition. | ||
520 | |a Drug shortages continue to be a threat to the health and welfare of numerous patients in the United States. For patients who depend on parenteral nutrition (PN) for survival, these shortages pose an even greater threat. Almost 75% of active drug shortages are sterile injectables, which includes PN components. Providing PN therapy is particularly challenging for clinicians because this is a complex medication and may contain 40 or more individual ingredients, of which multiple components may simultaneously be in limited supply. The availability of PN components must be considered during every step of the PN use process from ordering the PN prescription to administering this therapy to a patient. Alterations to a standardized process can lead to medication errors that can adversely affect patient outcomes and consume healthcare resources | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a adverse events | |
650 | 4 | |a drug compounding | |
650 | 4 | |a drug shortages | |
650 | 4 | |a parenteral nutrition | |
650 | 4 | |a patient safety | |
650 | 4 | |a risk management | |
650 | 7 | |a Parenteral Nutrition Solutions |2 NLM | |
650 | 7 | |a Pharmaceutical Preparations |2 NLM | |
650 | 7 | |a Prescription Drugs |2 NLM | |
700 | 1 | |a Mattox, Todd W |e verfasserin |4 aut | |
700 | 1 | |a Plogsted, Steve |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition |d 1986 |g 33(2018), 1 vom: 24. Feb., Seite 53-61 |w (DE-627)NLM012704393 |x 1941-2452 |7 nnns |
773 | 1 | 8 | |g volume:33 |g year:2018 |g number:1 |g day:24 |g month:02 |g pages:53-61 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/ncp.10052 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 33 |j 2018 |e 1 |b 24 |c 02 |h 53-61 |